The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.

The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.

View in: PubMed

subject areas

Antibodies, Monoclonal
Antigens, Differentiation, T-Lymphocyte
Antigens, Surface
Cadaver
Cyclosporins
Graft Rejection
Humans
Kidney Transplantation
T-Lymphocytes

authors with profiles

J. Richard Thistlethwaite